Cape Verde






Episode 048 - Colin Fisher, Portfolio Manager & President, StableView Asset Management

I went to a meeting and a podcast broke out. That's how this interview came about when I visited Colin Fisher at the mid-town Toronto offices of StableView Asset Management and, unexpectedly, he set up his podcast gear and we recorded a conversation primarily about a real estate techology company that he thinks has "fantastic" management, is undervalued and is going much higher. Colin also discusses his investment style, why technology companies with sub-$150 million market caps are his...


Episode 047 - Ken d'Entrecote, CEO, Medexus Pharmaceuticals

Investors have a compelling, low-risk, specialty pharmaceutical company under their noses they may not know about. Capital Ideas Media president and publisher Mark Bunting sits down with Ken d’Entremont, CEO of Medexus Pharmaceuticals (TSXV:MDP), to find out about the company’s model of licensing existing drugs, its fast-growing revenue and operating profit, and how close the firm is to making a transformational deal using its $27 million in cash.


Episode 046 - Dave Merheje, Business of Comedy Special

Capital Ideas Media publisher Mark Bunting talks to comedian and actor Dave Merheje, a late blooming success after nearly 20 years honing his craft. The 2019 Juno award winner for Best Comedy Album, Merheje opens up about his childhood as the son of naturally funny Lebanese immigrants, his comedic influences, internal struggles, why he cried when he got his first Netflix special, and how getting mugged in Los Angeles led him to find his authentic onstage voice.


Episode 045 - Sean Cullen, Business of Comedy Special

Capital Ideas Media publisher Mark Bunting has a wide-ranging discussion with comedian, actor and author Sean Cullen, who's forged a lengthy career through his unique, multi-faceted talents. Cullen discusses his childhood, early comedic influences, success with Corky and the Juice Pigs, on through to his solo career, U.S. experiences, what's wrong with the entertainment industry in Canada, his biggest career regret, his goals and what drives him to create.


Episode 044 - George Robinson, CEO, RavenQuest BioMed

Capital Ideas Media publisher Mark Bunting sits down with George Robinson, CEO of RavenQuest BioMed (CSE:RQB), and a thought leader in the cannabis sector. Robinson pulls the curtain back on the company’s unique technology, production growth, revenue and profitability projections, EU play, and First Nations and McGill University partnerships. RavenQuest BioMed has been building out and proving out for the last year, is now ready for prime time, and investors are waking up to the story.


Episode 043 - Kiran Sidhu, Founder, CEO, Halo Labs

Capital Ideas Media publisher Mark Bunting talks to Kiran Sidhu, Halo Labs’ (NEO:HALO;OTC:AGEEF) Founder and CEO, about how the company has become one of the fastest-growing firms in the cannabis sector in the U.S. Sidhu outlines Halo’s expansion in California and Nevada, it’s improving business in Oregon, a strategic deal in Lesotho, gives financial projections, and explains why the stock is undervalued compared to peers.


Episode 042 - Aras Azadian, Co-Founder, CEO, Chairman, Avicanna

Capital Ideas Media publisher Mark Bunting talks to Aras Azadian, the CEO of newly-public Avicanna (TSX:AVCN), a science-based, low-cost cannabis company with an impressive list of partners from Johnson & Johnson to Princess Margaret Hospital.


Episode 041 - SwapCast: Mark Bunting on the #HashtagFinance Podcast

Capital Ideas Media President & Publisher Mark Bunting in conversation with Grace Pedota on the Canadian Securities Exchange podcast, #Hashtag Finance. Mark talks about his favourite podcasts, the changing face of business news media, his early days in radio, the difference between covering sports and finance, and they play the word game, Blurt.


Episode 040 - Aaron Dunn, Senior Analyst, KeyStone Financial

Aaron Dunn, Senior Analyst at KeyStone Financial talks to Capital Ideas Media President & Publisher Mark Bunting in the audio version of a recent live stream broadcast. Aaron gives you six growth, dividend and U.S. top picks, and excellent insight into how KeyStone's Canadian Small Cap Growth portfolio has achieved an average annual return of more than 36% since 1998.


Episode 039 - Bruce Campbell, Founder & Portfolio Manager, StoneCastle Investment Management

Capital Ideas Media publisher Mark Bunting talks to Bruce Campbell, founder and portfolio manager of StoneCastle Investment Management. Bruce manages the Purpose Canadian Equity Growth Fund, which is higher by more than 30% this year, and ranked number one in its category. He also manages the StoneCastle Cannabis Growth Fund, which is up by more than 28% since its launch in September of 2018. Bruce brings you his macro view of the market, five small cap top picks, and answers viewer...


Episode 038 - Mark Goliger, CEO, National Access Cannabis

Capital Ideas Media publisher Mark Bunting talks to Mark Goliger, the CEO of National Access Cannabis (TSXV:META), the largest cannabis retailer in Canada. Goliger details the company’s expansion plans, its readiness for new products, and why investors should pay attention to the leverage and growth potential of the company.


Episode 037 - Tyler Robson, CEO, Valens GroWorks

Capital Ideas Media publisher Mark Bunting talks again with Tyler Robson, CEO of Valens GroWorks (CSE:VGW), the largest cannabis extractor in Canada. The company’s shares have more than doubled since his last visit. Find out about the company’s deals with Canopy Growth, Tilray and other top 10 licensed producers, and why Valens is very well-positioned for “Legalization 2.0” coming in October.


Episode 036 - Paul Pedersen, Co-Founder & CEO, Nextleaf Solutions

NextLeaf Solutions (CSE:OILS) beat multi-billion dollar public companies to the first U.S. patent for the extraction and purification of cannabinoids. The company has a facility in B.C. ready for “Legalization 2.0” to be a white label provider to many different types of consumer facing cannabis companies. Capital Ideas Media publisher Mark Bunting talks to Paul Pedersen, co-founder and CEO of Nextleaf, who was also a founder of Peace Naturals, which was bought by Cronos Group.


Episode 035 - Bob Groesbeck, Co-CEO, Planet 13

Capital Ideas TV travels to Las Vegas to Planet 13 (CSE:PLTH;OTC:PLNHF), the largest cannabis dispensary in the world. Capital Ideas Media publisher Mark Bunting talks to co-CEO Bob Groesbeck, who gives us a tour and details the company’s ambitious expansion plans for a 40,000 square foot entertainment complex. Planet 13’s stock has doubled since our first interview last July, and Groesbeck is very confident there is much higher revenue and profit in the future as the company rolls out its...


Episode 034 - Marc Seelenfreund, Founder, CEO, Siyata Mobile

Capital Ideas travels to Las Vegas for a wireless conference at the invitation of Siyata Mobile (TSXV:SIM;OTCQCX:SYATF). The company is kicking into a higher gear after striking distribution deals with AT&T, Motorola, FirstNet and Bell Mobility for its flagship product, the Uniden UV350, the “first and only” push-to-talk over cellular (PoC) device for commercial vehicles. Hear our conversation with Siyata mobile founder and CEO Marc Seelenfreund as he details why the company’s revenue,...


Episode 033 - Simon Hitzig, CEO, Accord Financial

Accord Financial (TSX:ACD) CEO Simon Hitzig talks with Capital Ideas Media publisher Mark Bunting about tripling the company’s loan portfolio, being more diverse than ever, and the record earnings that have resulted from the company’s five-year growth plan.


Episode 032 - Dr. Jack Regan, Founder, CEO, Lexagene Holdings

Capital Ideas Media publisher Mark Bunting sits down with Dr. Jack Regan, founder and CEO of Lexagene Holdings (TSXV:LXG;OTC:LXXGF). The company is on the verge of commercializing its pathogen detection system, which is faster and less expensive than current methods. Regan says Lexagene has already had exploratory talks with larger biotech firms that need this technology in their product line. That makes a buyout of Lexagene later this year a distinct possibility.


Episode 031 - Paul Beattie, Co-Founder, BT Global Growth

Capital Ideas Media President and Publisher Mark Bunting in conversation with Paul Beattie, co-founder of the BT Global Growth Fund, which has consistently beaten the market since inception in 2006 with an annualized return net of fees of 9%. Paul has Five Top Picks for you, talks about long/short strategies, the importance of cash flow, and explains how to profit from the inefficient Canadian market


Episode 030 - Dr. Zaki Rakib, Founder, CEO, Canna-V-Cell Sciences

Capital Ideas Media President and Publisher Mark Bunting sits down with Dr. Zaki Rakib, founder and CEO of Canna-V-Cell Sciences (CSE:CNVC), a company disrupting the burgeoning cannabis sector through bio farming. Rakib asks and answers the question: Why grow plants when all you want are the active ingredients? Canna-V-Cell’s proprietary and scaleable technology produces a cannabis powder at a fraction of the cost of traditional growing methods and uses a sliver of the space. The company...


Episode 029 - Bruce Campbell, Founder, StoneCastle Investment Management

Capital Ideas Media President and Publisher Mark Bunting in conversation with Bruce Campbell, who provides investors with Six Small Cap Top Picks, investing strategies and insights, and he answers viewer questions. At the time of this live interview, Bruce's Purpose Canadian Equity Growth Fund was the best-performing small-to-mid-cap mutual fund this year with a return of nearly 14%.